Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3045 EUR | +0.16% | +1.33% | -21.92% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.92% | 13.66M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.26% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Oncology Names New Chair, Interim CEO